TomBAvoider Posted February 18, 2020 Report Share Posted February 18, 2020 This is of course in a therapeutic setting, but in principle it shows that humans can tolerate rapa and even benefit from it - so it's 'proof of concept' to some degree: https://prostatecancernewstoday.com/2020/02/17/erapa-leads-to-boost-in-immune-cells-in-low-grade-prostate-cancer-patients-phase-1b-data-suggest/ Daily treatment with a low dose of eRapa, Emtora Biosciences' new formulation of the therapeutic agent rapamycin, was safe and well tolerated, and led to immune system cell boosting in patients with low-grade prostate cancer, according to data from a Phase 1b clinical trial. Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.